Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 438, 281 (17 November 2005) | doi:10.1038/438281a; Published online 16 November 2005
Wisdom of the crowd
Abstract
Decision makers, wrestling with thorny choices, are tapping into the collective foresight of ordinary people. Jim Giles reports.
Like all of their rivals in the pharmaceutical industry, executives at Eli Lilly routinely need to make tough predictions. How much of a new product do they expect to sell?
To read this story in full you will need to login or make a payment (see right).
